Maximum Recommended Starting Dose
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +4 more
-
Aurora, Colorado
- +2 more
Apr 18, 2022
Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,
Not yet recruiting
- Recurrent Bladder Carcinoma
- +2 more
- Pharmacokinetic Study
- Recombinant EphB4-HSA Fusion Protein
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))
Completed
- Advanced or Metastatic Solid Tumor
- Rogaratinib (BAY1163877)
- Copanlisib (BAY80-6946)
-
Los Angeles, California
- +19 more
Jul 13, 2022
Advanced Solid Tumors Trial in Seongnam-si, Seoul (NOV1501 (ABL001))
Completed
- Advanced Solid Tumors
- NOV1501 (ABL001)
-
Seongnam-si, Korea, Republic of
- +1 more
Jul 4, 2021
Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)
Recruiting
- Myeloproliferative Neoplasms
-
Herston, Queensland, Australia
- +22 more
Jun 30, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
Advanced Solid Tumor, Advanced Solid Malignancies Trial in China (PRJ1-3024)
Recruiting
- Advanced Solid Tumor
- Advanced Solid Malignancies
-
Zhengzhou, Henan, China
- +4 more
Jul 12, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 1, 2023
Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)
Active, not recruiting
- Advanced Nonhaematologic Malignancies
-
Philadelphia, Pennsylvania
- +20 more
Sep 23, 2022
B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +2 more
- Loncastuximab Tesirine
- +4 more
-
Pembroke Pines, Florida
- +19 more
Jul 22, 2022
Solid Tumor Trial in Los Angeles (laboratory biomarker analysis, pharmacological study, recombinant albumin fusion protein
Active, not recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- laboratory biomarker analysis
- +2 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Apr 1, 2021
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
NSCLC Trial in Canton, Houston (FWD1509 MsOH)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- FWD1509 MsOH
-
Canton, Ohio
- +1 more
Jul 20, 2022
Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)
Recruiting
- Non-Small-Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Apr 20, 2022
Acute Myeloid Leukemia Trial in Valencia (AFM28)
Recruiting
- Acute Myeloid Leukemia
-
Valencia, SpainHospital Universitari i Politècnic La Fe
Apr 5, 2023
Pediatric Oncology Trial in Worldwide (Regorafenib (BAY73-4506), Vincristine (Cellcristin®), Irinotecan (Irinotecan Cell
Active, not recruiting
- Pediatric Oncology
- Regorafenib (BAY73-4506)
- +2 more
-
Lyon, France
- +11 more
Jan 16, 2023
Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)
Not yet recruiting
- Acute Myeloid Leukemia
- Lymphoma, Mantle-Cell
- (no location specified)
Dec 22, 2022